123 related articles for article (PubMed ID: 33405434)
1. Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma.
Thota PN; Alkhayyat M; Gomez Cifuentes JD; Haider M; Bena J; McMichael J; Sohal DP; Raja S; Sanaka MR
J Clin Gastroenterol; 2022 Feb; 56(2):125-132. PubMed ID: 33405434
[TBL] [Abstract][Full Text] [Related]
2. Clinical Predictors of Locally Advanced Pathology in Esophageal Adenocarcinoma.
Gomez Cifuentes JD; Haider M; Sanaka MR; Kumar P; Bena J; McMichael J; Sohal DP; Raja S; Murthy S; Thota PN
Cureus; 2021 Oct; 13(10):e18991. PubMed ID: 34820244
[TBL] [Abstract][Full Text] [Related]
3. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy.
Bartel MJ; Wallace TM; Gomez-Esquivel RD; Raimondo M; Wolfsen HC; Woodward TA; Wallace MB
Gastrointest Endosc; 2017 Aug; 86(2):292-298. PubMed ID: 27889544
[TBL] [Abstract][Full Text] [Related]
4. Routine staging with endoscopic ultrasound in patients with obstructing esophageal cancer and dysphagia rarely impacts treatment decisions.
Mansfield SA; El-Dika S; Krishna SG; Perry KA; Walker JP
Surg Endosc; 2017 Aug; 31(8):3227-3233. PubMed ID: 27864719
[TBL] [Abstract][Full Text] [Related]
5. The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
Pech O; May A; Günter E; Gossner L; Ell C
Am J Gastroenterol; 2006 Oct; 101(10):2223-9. PubMed ID: 17032186
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of EUS in predicting advanced cancer among patients with Barrett's esophagus and high-grade dysplasia/early adenocarcinoma: systematic review and meta-analysis.
Qumseya BJ; Brown J; Abraham M; White D; Wolfsen H; Gupta N; Vennalaganti P; Sharma P; Wallace MB
Gastrointest Endosc; 2015 Apr; 81(4):865-74.e2. PubMed ID: 25442088
[TBL] [Abstract][Full Text] [Related]
7. Correlation between endoscopic forceps biopsies and endoscopic mucosal resection with endoscopic ultrasound in patients with Barrett's esophagus with high-grade dysplasia and early cancer.
Thota PN; Sada A; Sanaka MR; Jang S; Lopez R; Goldblum JR; Liu X; Dumot JA; Vargo J; Zuccarro G
Surg Endosc; 2017 Mar; 31(3):1336-1341. PubMed ID: 27444824
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic diagnosis and treatment of esophageal adenocarcinoma: introduction of Japan Esophageal Society classification of Barrett's esophagus.
Ishihara R; Goda K; Oyama T
J Gastroenterol; 2019 Jan; 54(1):1-9. PubMed ID: 29961130
[TBL] [Abstract][Full Text] [Related]
9. Young Adults With Esophageal Adenocarcinoma Present With More Advanced Stage Tumors and Have Shorter Survival Times.
Sawas T; Manrique GC; Iyer PG; Wang KK; Katzka DA
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1756-1762. PubMed ID: 30267861
[TBL] [Abstract][Full Text] [Related]
10. The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.
Cerfolio RJ; Bryant AS; Ohja B; Bartolucci AA; Eloubeidi MA
J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1232-41. PubMed ID: 15942562
[TBL] [Abstract][Full Text] [Related]
11. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
12. Relationship between Barrett's esophagus and colonic diseases: a role for colonoscopy in Barrett's surveillance.
Amano Y; Nakahara R; Yuki T; Murakami D; Ujihara T; Tomoyuki I; Sagami R; Suehiro S; Katsuyama Y; Hayasaka K; Harada H; Tada Y; Miyaoka Y; Fujishiro H
J Gastroenterol; 2019 Nov; 54(11):984-993. PubMed ID: 31240437
[TBL] [Abstract][Full Text] [Related]
13. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
14. Barrett Esophagus Length, Nodularity, and Low-grade Dysplasia are Predictive of Progression to Esophageal Adenocarcinoma.
Solanky D; Krishnamoorthi R; Crews N; Johnson M; Wang K; Wolfsen H; Fleischer D; Ramirez FC; Katzka D; Buttar N; Iyer PG
J Clin Gastroenterol; 2019; 53(5):361-365. PubMed ID: 29608452
[TBL] [Abstract][Full Text] [Related]
15. Persistence of nondysplastic Barrett's esophagus identifies patients at lower risk for esophageal adenocarcinoma: results from a large multicenter cohort.
Gaddam S; Singh M; Balasubramanian G; Thota P; Gupta N; Wani S; Higbee AD; Mathur SC; Horwhat JD; Rastogi A; Young PE; Cash BD; Bansal A; Vargo JJ; Falk GW; Lieberman DA; Sampliner RE; Sharma P
Gastroenterology; 2013 Sep; 145(3):548-53.e1. PubMed ID: 23714382
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
[TBL] [Abstract][Full Text] [Related]
17. Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study.
Sikkema M; Looman CW; Steyerberg EW; Kerkhof M; Kastelein F; van Dekken H; van Vuuren AJ; Bode WA; van der Valk H; Ouwendijk RJ; Giard R; Lesterhuis W; Heinhuis R; Klinkenberg EC; Meijer GA; ter Borg F; Arends JW; Kolkman JJ; van Baarlen J; de Vries RA; Mulder AH; van Tilburg AJ; Offerhaus GJ; ten Kate FJ; Kusters JG; Kuipers EJ; Siersema PD
Am J Gastroenterol; 2011 Jul; 106(7):1231-8. PubMed ID: 21577245
[TBL] [Abstract][Full Text] [Related]
18. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma.
Becker L; Huang Q; Mashimo H
Dis Esophagus; 2010 Feb; 23(2):168-74. PubMed ID: 19549212
[TBL] [Abstract][Full Text] [Related]
19. The impact of endoscopic ultrasound findings on clinical decision making in Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma.
Bulsiewicz WJ; Dellon ES; Rogers AJ; Pasricha S; Madanick RD; Grimm IS; Shaheen NJ
Dis Esophagus; 2014 Jul; 27(5):409-17. PubMed ID: 23016606
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasound is inadequate to determine which T1/T2 esophageal tumors are candidates for endoluminal therapies.
Bergeron EJ; Lin J; Chang AC; Orringer MB; Reddy RM
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):765-71: Discussion 771-3. PubMed ID: 24314788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
